Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Intocell, Inc

Clinical trials sponsored by Intocell, Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug ITC-6146RO enters first human tests for tough cancers Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New drug ITC-6146RO enters first human tests for tough cancers

Disease control Not yet recruiting

This early-phase trial tests an experimental drug called ITC-6146RO in about 102 adults with advanced or metastatic cancers (like prostate, lung, or breast cancer) that have not improved with standard treatments. The study has two parts: first, finding a safe dose, then checking …

Phase 1 • Sponsor: IntoCell, Inc • Aim: Disease control

Last updated Jun 27, 2026 09:07 UTC